Literature DB >> 22490724

Endovenous laser ablation for major varicose tributaries.

K A Myers1, A Clough, H Tilli.   

Abstract

OBJECTIVE: The purpose was to determine whether endovenous laser ablation (EVLA) could be used to treat major varicose tributaries as well as saphenous veins.
METHODS: From 173 major venous systems in 95 patients treated by EVLA over a 12-month period, 108 had major varicose tributaries, of which 78 (70%) were treated by attempted EVLA of the saphenous veins and associated tributaries.
RESULTS: Treatment was successful in 71 venous segments (83%). The lengths of saphenous veins treated were 3-46 (median 18) cm. and the lengths of tributaries treated were 3-38 (median 14) cm. The diameters of treated saphenous veins were 4-10 (median 6) mm, and the estimated mean diameters of treated tributaries were 3-8 (median 5) mm, as measured prior to operation with the patient in 45° reverse Trendelenburg on a tilt table. There were no early or delayed complications.
CONCLUSIONS: Major varicose tributaries as well as the saphenous veins can be treated by EVLA in approximately two-thirds of cases, with success in the majority selected and with no significant complications.

Entities:  

Keywords:  endovenous laser; varicose veins; venous tributaries

Mesh:

Year:  2013        PMID: 22490724     DOI: 10.1258/phleb.2011.011088

Source DB:  PubMed          Journal:  Phlebology        ISSN: 0268-3555            Impact factor:   1.740


  2 in total

1.  Targeted endovenous treatment of Giacomini vein insufficiency-associated varicose disease: considering the reflux patterns.

Authors:  Mehmet Mahir Atasoy; Burçak Gümüş; Ismail Caymaz; Levent Oğuzkurt
Journal:  Diagn Interv Radiol       Date:  2014-11       Impact factor: 2.630

2.  Feasibility and potential significance of prophylactic ablation of the major ascending tributaries in endovenous laser ablation (EVLA) of the great saphenous vein: A case series.

Authors:  Lars Müller; Jens Alm
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.